PN,30801
SC,0001
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,FThe world's first personalised mRNA
OL,7,Fcancer jab for melanoma ` which also
OL,8,Fhas the potential to stop lung,
OL,9,Fbladder and kidney cancer ` is being
OL,10,Ftested in British patients.
OL,12,FThe "gamechanger" jab, which offers
OL,13,Fhope of a cure, is custom-built for
OL,14,Feach person in just a few weeks.
OL,16,FIt works by telling the body to hunt
OL,17,Fdown cancer cells and prevent the
OL,18,Fdeadly disease from coming back.
OL,26,@tD@EOUtD@QO]
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G1/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30802
SC,0002
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,FA stage 2 trial of the jab, involving
OL,7,Fpharma firms Moderna and MSD, found it
OL,8,Fdramatically reduced the risk of the
OL,9,Fcancer returning in melanoma patients.
OL,11,FNow a final phase 3 trial has been
OL,12,Flaunched, led by University College
OL,13,FLondon Hospitals NHS Foundation Trust
OL,14,F(UCLH).
OL,16,FDr Heather Shaw, national co-
OL,17,Fordinating investigator for the trial,
OL,18,Fsaid the jab had the potential to cure
OL,19,Fpeople with melanoma and is being
OL,20,Ftested in other cancers.
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G2/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30803
SC,0003
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,FSharing the trial details exclusively
OL,7,Fwith the PA news agency, she said:
OL,8,F"This is one of the most exciting
OL,9,Fthings we've seen in a really long
OL,10,Ftime.
OL,12,F"This is a really finely honed tool.
OL,13,FTo be able to sit there and say to
OL,14,Fyour patients that you're offering
OL,15,Fthem something that's effectively like
OL,16,Fthe Fat Duck at Bray versus McDonald's
OL,17,F` it's that level of cordon bleu
OL,18,Fthat's coming to them.
OL,26,@pD@AOUtD@AOU
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G3/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30804
SC,0004
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,F"These things are hugely technical and
OL,7,Ffinely generated for the patient. The
OL,8,Fpatients are really excited about
OL,9,Fthem."
OL,11,FThe new jab is an individualised
OL,12,Fneoantigen therapy (INT) and is
OL,13,Fsometimes referred to as a cancer
OL,14,Fvaccine.
OL,16,FIt is designed to trigger the immune
OL,17,Fsystem so it can fight back against
OL,18,Fthe patient's specific type of cancer
OL,19,Fand tumour.
OL,26,@nD@AOUqD@FO]
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G4/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30805
SC,0005
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,FKnown as mRNA-4157 (V940), the jab is
OL,7,Fcreated to target tumour neoantigens,
OL,8,Fwhich are expressed by tumours in a
OL,9,Fparticular patient.
OL,11,FThese are markers on the tumour which
OL,12,Fcan potentially be recognised by the
OL,13,Fimmune system.
OL,15,FThe jab carries coding for up to 34
OL,16,Fneoantigens and activates an anti-
OL,17,Ftumour immune response based on the
OL,18,Funique mutations in a patient's cancer.
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G5/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30806
SC,0006
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,FIn order to create the jab, a sample
OL,7,Fof tumour is removed during the
OL,8,Fpatient's surgery, followed by DNA
OL,9,Fsequencing and the use of artificial
OL,10,Fintelligence.
OL,12,FThe result is a personalised anti-
OL,13,Fcancer jab which is specific to the
OL,14,Fpatient's tumour.
OL,16,FDr Shaw said: "This is very much an
OL,17,Findividualised therapy and it's far
OL,18,Fcleverer in some senses than a vaccine.
OL,26,@xD@OOU
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G6/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30807
SC,0007
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,F"It is absolutely custom built for the
OL,7,Fpatient ` you couldn't give this to
OL,8,Fthe next patient in the line because
OL,9,Fyou wouldn't expect it to work.
OL,11,F"They may have some shared new
OL,12,Fantigens, but they're likely to have
OL,13,Ftheir own very individual new antigens
OL,14,Fthat are important to their tumour and
OL,15,Fso, therefore, it is truly
OL,16,Fpersonalised."
OL,18,FThe ultimate aim is to cure patients
OL,19,Fof their cancer, Dr Shaw said.
OL,26,@nD@AOUsD@AOUxD@NO]
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G7/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30808
SC,0008
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,F"Absolutely, that's the drive. With
OL,7,F(this) therapy, what you're doing is
OL,8,Fdealing with the theoretical risk that
OL,9,Fthe cancer could recur.
OL,11,F"So there's nothing to see on scans,
OL,12,Fbut if there are some cells that have
OL,13,Fescaped that are below the detection
OL,14,Fof imaging... what we're trying to do
OL,15,Fis, on a patient-by-patient basis,
OL,16,Fgive treatment to eradicate any of
OL,17,Fthose rogue cells that might be
OL,18,Fsitting about.
OL,26,@nD@AOUsD@AOU
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G8/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30809
SC,0009
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,F"What we're trying to do is to push
OL,7,Fmore patients into that recurrence-
OL,8,Ffree survival bucket, which should
OL,9,Ftranslate into overall survival
OL,10,Fbenefit and a non-recurrence of those
OL,11,Fpatients over time, which equals cure."
OL,13,FPhase 2 data, published in December,
OL,14,Ffound that people with serious high-
OL,15,Frisk melanomas who received the jab
OL,16,Falongside MSD's immunotherapy Keytruda
OL,17,Fwere almost half (49%) as likely to
OL,18,Fdie or have their cancer come back
OL,19,Fafter three years than those who were
OL,20,Fgiven only Keytruda.
OL,26,@nD@AOUsD@gO]
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G9/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30810
SC,0010
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,FPatients received one milligram of the
OL,7,FmRNA vaccine every three weeks for a
OL,8,Fmaximum of nine doses, and 200
OL,9,Fmilligrams of Keytruda every three
OL,10,Fweeks (maximum 18 doses) for about a
OL,11,Fyear.
OL,13,FThe phase 3 global trial will now
OL,14,Finclude a wider range of patients, and
OL,15,Fhopes to recruit around 1,100 people.
OL,17,FThe UK arm aims to recruit at least 60
OL,18,Fto 70 patients across eight centres,
OL,19,Fincluding in London, Manchester,
OL,20,FEdinburgh and Leeds.
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G    G10/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30811
SC,0011
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,FThe therapy combination is also being
OL,7,Ftrialled in lung, bladder and kidney
OL,8,Fcancer.
OL,10,FOne of the first patients on the trial
OL,11,Fat UCLH is Steve Young, 52, from
OL,12,FStevenage.
OL,14,FHis "bump on the head" ` which he
OL,15,Fthinks he had for around a decade `
OL,16,Fturned out to be melanoma.
OL,18,FHe told PA it was a "massive shock" to
OL,19,Fbe diagnosed.
OL,26,@vD@EOUvD@VO]zD@UOUzD@cO]
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G    G11/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30812
SC,0012
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,F"I literally spent two weeks just
OL,7,Fthinking 'this is it'," he said.
OL,9,F"My dad died of emphysema when he was
OL,10,F57 and I actually thought 'I'm going
OL,11,Fto die younger than my dad'."
OL,13,FMr Young said when he was told about
OL,14,Fthe trial at UCLH it "really triggered
OL,15,Fmy geek radar".
OL,26,@nD@AOUoD@WO]qD@AOUsD@]O]vD@VOUwD@NO]
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G    G12/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30813
SC,0013
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,FHe added: "It really piqued my
OL,7,Finterest. As soon as they mentioned
OL,8,Fthis mRNA technology that was being
OL,9,Fused to potentially fight cancer, I
OL,10,Fwas just like, 'it sounds fascinating'
OL,11,Fand I still feel the same. I'm really,
OL,12,Freally excited.
OL,14,F"This is my best chance at stopping
OL,15,Fthe cancer in its tracks."
OL,17,FDr Shaw said: "I think there is a real
OL,18,Fhope that these will be the
OL,19,Fgamechangers in immunotherapy.
OL,26,@nD@KOUvD@AOUwD@ZO]yD@OOU
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G    G13/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30814
SC,0014
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,F"We've looked for a long time for
OL,7,Fsomething that would be additive to
OL,8,Fthe immunotherapies that we already
OL,9,Fhave ` that we know can be life-
OL,10,Fchanging for patients ` but with
OL,11,Fsomething that's got a really
OL,12,Facceptable side-effect profile.
OL,14,F"And these therapies look as if they
OL,15,Fmay offer that promise."
OL,17,FDr Shaw said side effects include
OL,18,Ftiredness and a sore arm where the jab
OL,19,Fwas given.
OL,26,@nD@AOUvD@AOUwD@XO]
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G    G14/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30815
SC,0015
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,F"So it appears to be relatively
OL,7,Ftolerable and actually no worse than
OL,8,Fhaving a flu vaccine or a Covid jab
OL,9,Ffor the majority of patients," she
OL,10,Fsaid.
OL,12,FProfessor Lawrence Young, from the
OL,13,FUniversity of Warwick, said: "This is
OL,14,Fone of the most exciting developments
OL,15,Fin modern cancer therapy.
OL,26,@nD@AOUqD@^O]uD@^OU
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G    G15/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30816
SC,0016
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,F"Combining a personalised cancer
OL,7,Fvaccine to boost a specific immune
OL,8,Fresponse to the patient's tumour along
OL,9,Fwith using an antibody to release the
OL,10,Fbrake on the body's immune response
OL,11,Fhas already shown great promise in
OL,12,Fpatients whose original skin cancer
OL,13,F(melanoma) has been removed.
OL,26,@nD@AOU
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G    G16/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30817
SC,0017
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,F"Interest in cancer vaccines has been
OL,7,Freignited in recent years by a deeper
OL,8,Funderstanding of how the body controls
OL,9,Fimmune responses and by the advent of
OL,10,FmRNA vaccines which makes developing a
OL,11,Fvaccine based on the immune profile of
OL,12,Fa patient's own tumour much more
OL,13,Fstraightforward.
OL,15,F"The hope is that this approach could
OL,16,Fbe extended to other cancers such
OL,17,Fthose of the lung and colon."
OL,26,@nD@AOUwD@AOUyD@]O]
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G    G17/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
PN,30818
SC,0018
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F308A1714123501
OL,3,CBritish patients test world's first
OL,4,Cpersonalised mRNA jab for melanoma
OL,6,FVassiliki Karantza, associate vice
OL,7,Fpresident of MSD Research
OL,8,FLaboratories, said: "At MSD, we are
OL,9,Fcommitted to driving research forward
OL,10,Ffor innovative modalities in earlier
OL,11,Fstages of cancer, where we can have
OL,12,Fthe most meaningful impact on patients.
OL,14,F"This trial demonstrates our continued
OL,15,Fefforts to advance novel treatment
OL,16,Foptions for patients with melanoma and
OL,17,Fwe look forward to the expansion of
OL,18,Four comprehensive clinical development
OL,19,Fprogramme into additional tumour
OL,20,Ftypes."
OL,26,@pD@UOUvD@AOU|D@GO]
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G    G18/18
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,309,307,8ff,8ff,8ff,8ff
